WASHINGTON — Democrats finally achieved a win over the pharmaceutical industry this month when they passed the most aggressive drug pricing reform in decades. But their victory could be short-lived.
Even before the law passed, the pharmaceutical industry was threatening to sue to block the reforms, with both the brand drug lobby PhRMA and the Biotechnology Innovation Organization issuing veiled promises to “explore every opportunity” or “explore all avenues” to stop the law from taking effect.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
